Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32026 Page 1 of 6
`
`EXHIBIT 1
`
`DECLARATION OF TRENT D. TANNER
`IN SUPPORT OF
`NUVASIVE'S OPPOSITION TO
`DEFENDANTS' MOTIONS IN LIMINE NOS. 1-10
`
`
`
`
`
`
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32027 Page 2 of 6
`
`UNITED STATES DISTRICT COURT
`
`SOUTHERN DISTRICT OF CALIFORNIA
`
`SAN DIEGO DIVISION
`
`CASE NO.: 18-cv-00347-CAB-MDD
`
`[PROPOSED] PRETRIAL ORDER
`
`Judge: Hon. Cathy Ann Bencivengo
`Courtroom: 15A
`
`Trial Date: December 8, 2021
`
`))
`
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`NUVASIVE, INC., a Delaware
`corporation,
`
`Plaintiff,
`
`v.
`
`ALPHATEC HOLDINGS, INC., a
`Delaware corporation, and ALPHATEC
`SPINE, INC., a California corporation,
`
`Defendants.
`
`[PROPOSED] PRETRIAL ORDER
`
`18-cv-00347-CAB-MDD
`
`
`
`1 1
`
`
`
`2 2
`
`
`
`3 3
`
`
`
`4 4
`
`
`
`5 5
`
`
`
`6 6
`
`
`
`7 7
`
`
`
`8 8
`
`
`
`9 9
`
`
`
`10 10
`
`
`
`11 11
`
`
`
`12 12
`
`
`
`13 13
`
`
`
`14 14
`
`
`
`15 15
`
`
`
`16 16
`
`
`
`17 17
`
`
`
`18 18
`
`
`
`19 19
`
`
`
`20 20
`
`
`
`21 21
`
`
`
`22 22
`
`
`
`23 23
`
`
`
`24 24
`
`
`
`25 25
`
`
`
`26 26
`
`
`
`27 27
`
`
`
`28 28
`
`EXHIBIT 1
`Page 1
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32028 Page 3 of 6
`
`
`
`1 1
`
`
`
`2 2
`
`
`
`3 3
`
`
`
`4 4
`
`
`
`5 5
`
`
`
`6 6
`
`
`
`7 7
`
`
`
`8 8
`
`
`
`9 9
`
`Following pretrial proceedings pursuant to Fed. R. Civ. P. 16 and CivLR
`
`16.1.f.6.
`
`IT IS ORDERED:
`
`I.
`
`NATURE OF THE CASE
`
`1.
`
`This is an action for patent infringement. In this case, Plaintiff
`
`NuVasive, Inc. (or “NuVasive” for short) alleges that Defendants Alphatec
`
`Holdings, Inc. and Alphatec Spine, Inc. (collectively “Alphatec” for short) infringe
`
`three U.S. Patents. The first patent is U.S. Patent Number 8,439,832, which the
`
`Court and Parties will often refer to by the last three digits of the patent number, so
`
`
`
`10 10
`
`that is “the ’832 Patent.” The second patent is U.S. Patent Number 7,819,801, which
`
`
`
`11 11
`
`the Court and Parties will often refer to as “the ’801 Patent.” The third patent is U.S.
`
`
`
`12 12
`
`Patent Number 9,974,531, which the Court and Parties will often refer to as “the
`
`
`
`13 13
`
`’531 Patent”. The ’832 Patent, ’801 Patent, and ’531 Patent are the “Asserted
`
`
`
`14 14
`
`Patents.” The Asserted Patents generally relate to the field of spine surgery.
`
`
`
`15 15
`
`NuVasive owns the Asserted Patents. NuVasive alleges that certain of Alphatec’s
`
`
`
`16 16
`
`surgical access systems and implants infringe the Asserted Patents.
`
`
`
`17 17
`
`2.
`
`[NuVasive’s Position: The next paragraph of the neutral statement
`
`
`
`18 18
`
`should read as follows: “The Court has already determined that Alphatec infringes
`
`
`
`19 19
`
`the ’832 Patent. As to the ’801 Patent and the ’531 Patent, NuVasive has the burden
`
`
`
`20 20
`
`of proving that the accused products infringe those patents by a preponderance of
`
`
`
`21 21
`
`the evidence.”]; [Alphatec’s Position: The next paragraph of the neutral statement
`
`
`
`22 22
`
`should read as follows: “NuVasive has the burden of proving that the accused
`
`
`
`23 23
`
`products infringe the ’801 Patent and the ’531 Patent by a preponderance of the
`
`
`
`24 24
`
`evidence. Alphatec denies infringement of the ’801 Patent and ’531 Patent. You
`
`
`
`25 25
`
`will not be asked to decide whether Alphatec has infringed the ’832 Patent.”]
`
`
`
`26 26
`
`3.
`
`Alphatec denies willful infringement as to each Asserted Patent.
`
`
`
`27 27
`
`Alphatec also alleges that each of the Asserted Patents is invalid. Alphatec has the
`
`
`
`28 28
`
`[PROPOSED] PRETRIAL ORDER
`
`1
`
`18-cv-00347-CAB-MDD
`
`EXHIBIT 1
`Page 2
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32029 Page 4 of 6
`
`
`
`1 1
`
`
`
`2 2
`
`
`
`3 3
`
`
`
`4 4
`
`
`
`5 5
`
`
`
`6 6
`
`
`
`7 7
`
`
`
`8 8
`
`
`
`9 9
`
`burden of proving that each Asserted Patent is invalid by clear and convincing
`
`evidence.
`
`4.
`
`NuVasive seeks damages for Alphatec’s infringement of the Asserted
`
`Patents and contends that such infringement has been, and continues to be, willful.
`
`5.
`
` Alphatec contends that NuVasive is not entitled to any damages
`
`because Alphatec does not infringe any valid claim of the Asserted Patents.
`
`II.
`
`CAUSES OF ACTION
`
`A.
`
`6.
`
`NuVasive’s Causes of Action
`
`NuVasive filed its Amended Complaint for Patent Infringement [Doc.
`
`
`
`10 10
`
`No. 110] on September 13, 2018 (“Operative Complaint”) originally alleging Eleven
`
`
`
`11 11
`
`causes of action for patent infringement.
`
`
`
`12 12
`
`7.
`
`[NuVasive’s Position: Omit the following paragraph]; [Alphatec’s
`
`
`
`13 13
`
`Position: “On September 3, 2021, the Court provided its Notes for Scheduling
`
`
`
`14 14
`
`Conference, identifying the patents and issues remaining in this case after the
`
`
`
`15 15
`
`Court’s previous rulings [Doc. Nos. 281, 282, 333]. On September 7, 2021, the
`
`
`
`16 16
`
`Court ordered NuVasive to provide a final disclosure of patent claims to be asserted
`
`
`
`17 17
`
`at trial by September 24, 2021 [Doc. No. 335].”]
`
`
`
`18 18
`
`8.
`
`On September 24, 2021, NuVasive provided its Final Disclosure of
`
`
`
`19 19
`
`Patent Claims to be Asserted at Trial [Doc No. 336]. [NuVasive’s Position:
`
`
`
`20 20
`
`“Pursuant to Doc. No. 336, the following causes of action will be tried to the jury at
`
`
`
`21 21
`
`the December 2021 trial:
`
`
`
`22 22
`
`
`
`23 23
`
`
`
`24 24
`
`
`
`25 25
`
`
`
`26 26
`
`
`
`27 27
`
`™ Third Cause of Action: Direct and indirect infringement of the ’832 Patent
`under 35 U.S.C. §§ 271(a)–(c);
`
`™ First Cause of Action: Direct and indirect infringement of the ’801 Patent
`under 35 U.S.C. §§ 271(a)–(c);
`
`™ Tenth Cause of Action: Direct and indirect infringement of the ’531 Patent
`under 35 U.S.C. §§ 271(a)–(c).”]
`
`9.
`
`[Alphatec’s Position: “Pursuant to Doc. No. 336, only the following
`
`
`
`28 28
`
`causes of action remain to be tried to the jury”]:
`
`[PROPOSED] PRETRIAL ORDER
`
`2
`
`18-cv-00347-CAB-MDD
`
`EXHIBIT 1
`Page 3
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32030 Page 5 of 6
`
`Dated: November 5, 2021
`
`Respectfully submitted,
`
`WILSON SONSINI GOODRICH & ROSATI
`
`By:
`Wendy L. Devine (SBN 246337)
`
`Morris Fodeman (pro hac vice)
`mfodeman@wsgr.com
`1301 Avenue of the Americas, 40th Floor
`New York, NY 10019-6022
`(212) 999-5800
`
`Wendy L. Devine (SBN 246337)
`wdevine@wsgr.com
`One Market Plaza
`Spear Tower, Suite 3300
`San Francisco, California 94105-1126
`(415) 947-2000
`
`Natalie J. Morgan (SBN 211143)
`nmorgan@wsgr.com
`12235 El Camino Real
`San Diego, CA 92130
`(858) 350-2300
`
`HILGERS GRABEN PLLC
`Michael T. Hilgers (pro hac vice)
`mhilgers@hilgersgraben.com
`575 Fallbrook Blvd., Suite 202
`Lincoln, NE 68521
`(402) 218-2106
`
`Attorneys for Plaintiff NuVasive, Inc.
`
`
`
`1 1
`
`
`
`2 2
`
`
`
`3 3
`
`
`
`4 4
`
`
`
`5 5
`
`
`
`6 6
`
`
`
`7 7
`
`
`
`8 8
`
`
`
`9 9
`
`
`
`10 10
`
`
`
`11 11
`
`
`
`12 12
`
`
`
`13 13
`
`
`
`14 14
`
`
`
`15 15
`
`
`
`16 16
`
`
`
`17 17
`
`
`
`18 18
`
`
`
`19 19
`
`
`
`20 20
`
`
`
`21 21
`
`
`
`22 22
`
`
`
`23 23
`
`
`
`24 24
`
`
`
`25 25
`
`
`
`26 26
`
`
`
`27 27
`
`
`
`28 28
`
`[PROPOSED] PRETRIAL ORDER
`
`29
`
`18-cv-00347-CAB-MDD
`
`EXHIBIT 1
`Page 4
`
`

`

`Case 3:18-cv-00347-CAB-MDD Document 350-1 Filed 11/06/21 PageID.32031 Page 6 of 6
`
`
`
`1 1
`
`
`
`2 2
`
`
`
`3 3
`
`
`
`4 4
`
`
`
`5 5
`
`
`
`6 6
`
`
`
`7 7
`
`
`
`8 8
`
`
`
`9 9
`
`
`
`10 10
`
`
`
`11 11
`
`
`
`12 12
`
`
`
`13 13
`
`
`
`14 14
`
`
`
`15 15
`
`
`
`16 16
`
`
`
`17 17
`
`
`
`18 18
`
`
`
`19 19
`
`
`
`20 20
`
`
`
`21 21
`
`
`
`22 22
`
`
`
`23 23
`
`
`
`24 24
`
`
`
`25 25
`
`
`
`26 26
`
`
`
`27 27
`
`
`
`28 28
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a true and correct copy of the foregoing
`
`document has been served on this date to all current and/or opposing counsel of
`
`record, if any to date, who are deemed to have consented to electronic service via
`
`the Court’s CM/ECF system per CivLR 5.4(d). Any other counsel of record will be
`
`served by electronic mail, facsimile and/or overnight delivery.
`
`I declare under penalty of perjury under the laws of the United States of
`
`America that the above is true and correct. Executed this 8th day of October 2021
`
`at Los Angeles, California.
`
`By: /s/ Soo Kim
`Soo Kim
`
`CERTIFICATE OF SERVICE
`
`1
`
`18-cv-00347-CAB-MDD
`
`EXHIBIT 1
`Page 5
`
`